Eight-epi-PGF2alpha: a possible marker of lipid peroxidation in term infants with severe pulmonary disease

J Pediatr. 1998 Feb;132(2):349-51. doi: 10.1016/s0022-3476(98)70459-7.

Abstract

A prostaglandin F2-like compound, 8-epi-PGF2alpha, formed from oxidation of arachidonate, has been proposed as an indicator of lipid peroxidation. We determined whether tracheal aspirate or urinary 8-epi-PGF2alpha levels would differ over time or between infants in a control group and infants with severe respiratory failure. We correlated tracheal aspirate 8-epi-PGF2alpha levels with the fraction of inspired oxygen and with mean airway pressures at 24 and 48 hours of life. Levels in tracheal aspirates were in the range of 0 to 36 pg/microg of fSC of IgA and were higher in infants with severe pulmonary disorders compared with those in infants in the control group (p < 0.02). Urinary concentrations did not discriminate between sick infants and infants in the control group.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / analysis
  • Dinoprost / analogs & derivatives*
  • Dinoprost / analysis
  • Dinoprost / urine
  • Exudates and Transudates / chemistry
  • F2-Isoprostanes
  • Humans
  • Immunoenzyme Techniques
  • Infant, Newborn
  • Lipid Peroxidation*
  • Lung Diseases / physiopathology*
  • Respiratory Distress Syndrome, Newborn / physiopathology*
  • Respiratory Distress Syndrome, Newborn / urine
  • Trachea

Substances

  • Biomarkers
  • F2-Isoprostanes
  • 8-epi-prostaglandin F2alpha
  • Dinoprost